SUMMARY Possible alterations in mesenteric vascular reactivity to norepinephrine, angiotensin II, and arginine vasopressin and its relationship to prostaglandins in dexamethasone-induced hypertension in rats were investigated. The animals were treated with dexamethasone or its vehicle (sesame oil) for I day (1.8 mg/kg) and for 14 days (1.8 mg/kg/wk). The superior mesenteric artery with its branches was isolated and perfused with Tyrode's solution at a constant flow rate of 5 ml/min. Administration of norepinephrine (1-10 nmol), arginine vasopressin (0.03-0.3 nmol), or angiotensin II (0.1-1 nmol) produced vasoconstriction and increased the output of 6-keto-prostaglandin F ln and prostaglandin E 2 in a dose-related manner in mesenteric vessels. Administration of 10 nmol bradykinin or 19 nmol A23187 enhanced the output of prostaglandins without altering vascular tone. The vasoconstrictor response to arginine vasopressin, but not norepinephrine or angiotensin II, was enhanced in mesenteric vessels from rats treated with dexamethasone for 14 days but not for 1 day. In contrast, the output of basal as well as norepinephrine, arginine vasopressin, angiotensin II, bradykinin, or A23187-induced prostaglandin output was significantly reduced in mesenteric vessels from rats treated with dexamethasone for 1 or 14 days. Prostaglandin output in mesenteric arteries from rats treated with dexamethasone for 1 and 14 days was not different. These data indicate that dexamethasone treatment for longer but not for shorter periods results in a selective increase in vascular reactivity of mesenteric vessels to arginine vasopressin that is independent of prostaglandin synthesis. The increase in vascular reactivity to arginine vasopressin during long-term dexamethasone treatment may contribute to the development or maintenance, or both, of glucocorticoid-induced hypertension. 198S) KKV WORDS • dexamethasone-induced hypertension • vascular responsiveness 6-keto-prostaglandin F, ( , • prostaglandin E 2 • perfused mesenteric artery G LUCOCORT1COID treatment over a pro-' longed period in some animal species or glucocorticoid excess in patients with Cushing's syndrome results in arterial hypertension.1 " 1 The demonstration by some investigators that glucocorticoid excess enhances the pressor response and vascular reactivity to norepinephrine (NE) in animals and humans suggests that this effect contributes to the pathogenesis of glucocorticoid-induced hypertension.5 "" The increase in vascular reactivity to NE caused by long-term treatment with glucocorticoids appears to be unrelated to their action to inhibit extraneuronal uptake or meta-